Amprius Technologies' New Leadership, Manufacturing Capacity to Help Shape Long-term Pricing Strategy, Oppenheimer Says

MT Newswires Live04:02

Amprius Technologies' (AMPX) new leadership and over 2 gigawatt-hours of available manufacturing capacity will enable the company prioritize its long-term pricing strategy to increase value capture, Oppenheimer said in a Tuesday research report.

The company has a multi-year lead on battery technology for defense applications, and its balance sheet is well-positioned to drive sustainable growth, the brokerage stated.

Clients transitioning to production orders from sampling cells could be a drag on near-term revenue growth, but provides a pathway to higher margins and operating leverage, according to the note.

The company's efforts to transition clients to SiCore from the SiMaxx product line could be complete by H2 2026 and support expectations that the company reaches profitability in Q4, analysts wrote.

The brokerage said it now expects a fiscal 2025 loss of $0.20 per share on revenue of $72.8 million from a loss of $0.19 and revenue of $82.8 million earlier. It guided for 2027 EPS of $0.07 on revenue of $215 million. For 2028, it expects EPS of $0.61 on revenue of $433 million.

The brokerage said it reiterated its outperform rating on the stock and price target of $17 per share.

Price: 8.65, Change: -0.42, Percent Change: -4.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment